Trial Profile
A Phase 1 study on single oral dose administration of ONO-2160/CD in healthy adult male subjects and Parkinson's disease patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Carbidopa/ONO 2160 (Primary) ; Levodopa/carbidopa; ONO 2160
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 07 Jun 2016 New trial record